Exploratory analysis using machine learning to predict for chest wall pain in patients with stage I non‐small‐cell lung cancer treated with stereotactic body radiation therapy
Abstract:Background and purposeChest wall toxicity is observed after stereotactic body radiation therapy (SBRT) for peripherally located lung tumors. We utilize machine learning algorithms to identify toxicity predictors to develop dose–volume constraints.Materials and methodsTwenty‐five patient, tumor, and dosimetric features were recorded for 197 consecutive patients with Stage I NSCLC treated with SBRT, 11 of whom (5.6%) developed CTCAEv4 grade ≥2 chest wall pain. Decision tree modeling was used to determine chest w… Show more
“…Given the result from our machine learning analysis that none of the 35 features analyzed performed better than a random classifier, this suggests that our currently utilized clinical, demographic, and dosimetric features could be inadequate to reliably predict radiation esophagitis. One can conclude that we are not currently collecting and capturing the appropriate features to allow a machine learning workflow to predict grade 3 radiation esophagitis, as we were successfully able to do when using machine learning to predict for pneumonitis in LA-NSCLC [41] and chest wall toxicity in early stage NSCLC [42]. As such, we encourage other investigators to explore and develop new markers directed at this toxicity.…”
a b s t r a c tBackground and Purpose: Radiation esophagitis is a clinically important toxicity seen with treatment for locally-advanced non-small cell lung cancer. There is considerable disagreement among prior studies in identifying predictors of radiation esophagitis. We apply machine learning algorithms to identify factors contributing to the development of radiation esophagitis to uncover previously unidentified criteria and more robust dosimetric factors. Materials and Methods: We used machine learning approaches to identify predictors of grade 3 radiation esophagitis in a cohort of 202 consecutive locally-advanced non-small cell lung cancer patients treated with definitive chemoradiation from 2008 to 2016. We evaluated 35 clinical features per patient grouped into risk factors, comorbidities, imaging, stage, histology, radiotherapy, chemotherapy and dosimetry. Univariate and multivariate analyses were performed using a panel of 11 machine learning algorithms combined with predictive power assessments. Results: All patients were treated to a median dose of 66.6 Gy at 1.8 Gy per fraction using photon (89.6%) and proton (10.4%) beam therapy, most often with concurrent chemotherapy (86.6%). 11.4% of patients developed grade 3 radiation esophagitis. On univariate analysis, no individual feature was found to predict radiation esophagitis (AUC range 0.45-0.55, p 0.07). In multivariate analysis, all machine learning algorithms exhibited poor predictive performance (AUC range 0.46-0.56, p 0.07). Conclusions: Contemporary machine learning algorithms applied to our modern, relatively large institutional cohort could not identify any reliable predictors of grade 3 radiation esophagitis. Additional patients are needed, and novel patient-specific and treatment characteristics should be investigated to develop clinically meaningful methods to mitigate this survival altering toxicity.
“…Given the result from our machine learning analysis that none of the 35 features analyzed performed better than a random classifier, this suggests that our currently utilized clinical, demographic, and dosimetric features could be inadequate to reliably predict radiation esophagitis. One can conclude that we are not currently collecting and capturing the appropriate features to allow a machine learning workflow to predict grade 3 radiation esophagitis, as we were successfully able to do when using machine learning to predict for pneumonitis in LA-NSCLC [41] and chest wall toxicity in early stage NSCLC [42]. As such, we encourage other investigators to explore and develop new markers directed at this toxicity.…”
a b s t r a c tBackground and Purpose: Radiation esophagitis is a clinically important toxicity seen with treatment for locally-advanced non-small cell lung cancer. There is considerable disagreement among prior studies in identifying predictors of radiation esophagitis. We apply machine learning algorithms to identify factors contributing to the development of radiation esophagitis to uncover previously unidentified criteria and more robust dosimetric factors. Materials and Methods: We used machine learning approaches to identify predictors of grade 3 radiation esophagitis in a cohort of 202 consecutive locally-advanced non-small cell lung cancer patients treated with definitive chemoradiation from 2008 to 2016. We evaluated 35 clinical features per patient grouped into risk factors, comorbidities, imaging, stage, histology, radiotherapy, chemotherapy and dosimetry. Univariate and multivariate analyses were performed using a panel of 11 machine learning algorithms combined with predictive power assessments. Results: All patients were treated to a median dose of 66.6 Gy at 1.8 Gy per fraction using photon (89.6%) and proton (10.4%) beam therapy, most often with concurrent chemotherapy (86.6%). 11.4% of patients developed grade 3 radiation esophagitis. On univariate analysis, no individual feature was found to predict radiation esophagitis (AUC range 0.45-0.55, p 0.07). In multivariate analysis, all machine learning algorithms exhibited poor predictive performance (AUC range 0.46-0.56, p 0.07). Conclusions: Contemporary machine learning algorithms applied to our modern, relatively large institutional cohort could not identify any reliable predictors of grade 3 radiation esophagitis. Additional patients are needed, and novel patient-specific and treatment characteristics should be investigated to develop clinically meaningful methods to mitigate this survival altering toxicity.
“…Recently, there is a tremendous increase in the use of ML in different areas of radiation oncology, such as treatment planning optimization, segmentation, radiation physics quality assurance, contouring or image‐guided radiotherapy . In this paper, we focus on ML for radiation outcome modeling …”
Aims
This review paper intends to summarize the application of machine learning to radiotherapy outcome modeling based on structured and un‐structured radiation oncology datasets.
Materials and methods
The most appropriate machine learning approaches for structured datasets in terms of accuracy and interpretability are identified. For un‐structured datasets, deep learning algorithms are explored and a critical view of the use of these approaches in radiation oncology is also provided.
Conclusions
We discuss the challenges in radiotherapy outcome prediction, and suggest to improve radiation outcome modeling by developing appropriate machine learning approaches where both accuracy and interpretability are taken into account.
“…Lung cancer RT may cause chest pain due to rib fracture, radiation-induced neuropathy of the intercostal nerves or nerve branches, chest wall edema, or chest wall fibrosis. However, the only study we found that specifically investigated chest pain is the one by (34). The authors utilized decision tree and RF methods to identify robust features predictive of chest wall pain in a cohort of 197 patients.…”
In order to limit radiotherapy (RT)-related side effects, effective toxicity prediction and assessment schemes are essential. In recent years, the growing interest toward artificial intelligence and machine learning (ML) within the science community has led to the implementation of innovative tools in RT. Several researchers have demonstrated the high performance of ML-based models in predicting toxicity, but the application of these approaches in clinics is still lagging, partly due to their low interpretability. Therefore, an overview of contemporary research is needed in order to familiarize practitioners with common methods and strategies. Here, we present a review of ML-based models for predicting and classifying RT-induced complications from both a methodological and a clinical standpoint, focusing on the type of features considered, the ML methods used, and the main results achieved. Our work overviews published research in multiple cancer sites, including brain, breast, esophagus, gynecological, head and neck, liver, lung, and prostate cancers. The aim is to define the current state of the art and main achievements within the field for both researchers and clinicians.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.